EyePoint Pharmaceuticals (EYPT) Competitor Comparison
We are evaluating the key criteria listed to compare EyePoint Pharmaceuticals (EYPT) against its competitors in the Biotechnology industry.
Market Capitalization
104 / 368Gross Profits
78 / 278Total Revenue
131 / 300EBITDA
179 / 337Free Cashflow
24 / 352Quick Ratio
285 / 357Earnings per Share
193 / 359Dividend yield
0 / 6Total Cash
192 / 358Performance 3 years
144 / 368Performance 5 years
158 / 368Performance 10 years
184 / 368Linearity 3 years
77 / 368Linearity 5 years
57 / 368Linearity 10 years
168 / 368Total Rank
123 / 368Dividend Rank
126 / 368Valuation Rank
39 / 368Piotroski Rank
278 / 368Muliplier Rank
343 / 368Quick Ratio - EYPT ranking 285 / 357
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.